102 related articles for article (PubMed ID: 1731595)
1. Parenteral followed by oral ofloxacin for nosocomial pneumonia and community-acquired pneumonia requiring hospitalization.
Gentry LO; Rodriguez-Gomez G; Kohler RB; Khan FA; Rytel MW
Am Rev Respir Dis; 1992 Jan; 145(1):31-5. PubMed ID: 1731595
[TBL] [Abstract][Full Text] [Related]
2. Intravenous followed by oral ofloxacin in the treatment of community acquired lower respiratory tract infections in adults requiring hospitalisation.
Liam CK; Aziah AM; Lim KH; Wong CM
Med J Malaysia; 2000 Sep; 55(3):304-7. PubMed ID: 11200708
[TBL] [Abstract][Full Text] [Related]
3. Ofloxacin treatment of difficult infections of the skin and skin structure.
Gentry LO; Rodriguez-Gomez G
Cutis; 1993 Jan; 51(1):55-8. PubMed ID: 8419113
[TBL] [Abstract][Full Text] [Related]
4. Treatment of community-acquired pneumonia with ofloxacin.
Youngchaiyud P; Permpikul C; Thamlikitkul V; Charoenratanakul S; Nana A
J Med Assoc Thai; 1991 Feb; 74(2):61-5. PubMed ID: 2056259
[TBL] [Abstract][Full Text] [Related]
5. Efficacy of intravenous ofloxacin: a French multicentre trial in 185 patients.
Mouton Y; Leroy O; Beuscart C; Sivery B; Senneville E; Chidiac C; Beaucaire G; Vincent du Laurier M
J Antimicrob Chemother; 1990 Nov; 26 Suppl D():115-21. PubMed ID: 2286586
[TBL] [Abstract][Full Text] [Related]
6. Oral levofloxacin in the treatment of community-acquired pneumonia.
Nicodemo AC; Lima Nicodemo E; Idrahim KY
Braz J Infect Dis; 2000 Apr; 4(2):61-6. PubMed ID: 10795070
[TBL] [Abstract][Full Text] [Related]
7. A comparative evaluation of oral ofloxacin versus intravenous cefotaxime therapy for serious skin and skin structure infections.
Gentry LO; Rodriguez-Gomez G; Zeluff BJ; Khoshdel A; Price M
Am J Med; 1989 Dec; 87(6C):57S-60S. PubMed ID: 2690621
[TBL] [Abstract][Full Text] [Related]
8. Oral ofloxacin therapy for lower respiratory tract infection.
Gentry LO; Lipsky B; Farber MO; Tucker B; Rodriguez-Gomez G
South Med J; 1992 Jan; 85(1):14-8. PubMed ID: 1734527
[TBL] [Abstract][Full Text] [Related]
9. [The combination of penicillin G and ofloxacin: a response to the empirical treatment of community acquired pneumonia].
Dopff C; Mertes PM; Nace L; Gerard A; Voiriot P; Preiss MA; May T; Canton P; Dureux JB
Pathol Biol (Paris); 1990 Jun; 38(5 ( Pt 2)):526-9. PubMed ID: 2385449
[TBL] [Abstract][Full Text] [Related]
10. Oral ofloxacin for the treatment of acute bacterial pneumonia: use of a nontraditional protocol to compare experimental therapy with "usual care" in a multicenter clinical trial.
Sanders WE; Morris JF; Alessi P; Makris AT; McCloskey RV; Trenholme GM; Iannini P; Bittner MJ
Am J Med; 1991 Sep; 91(3):261-6. PubMed ID: 1892146
[TBL] [Abstract][Full Text] [Related]
11. Sources of multidrug-resistant Acinetobacter baumannii and its role in respiratory tract colonization and nosocomial pneumonia in intensive care unit patients.
Huang J; Chen EZ; Qu HP; Mao EQ; Zhu ZG; Ni YX; Han LZ; Tang YQ
Chin Med J (Engl); 2013; 126(10):1826-31. PubMed ID: 23673094
[TBL] [Abstract][Full Text] [Related]
12. Health care-associated pneumonia and community-acquired pneumonia: a single-center experience.
Micek ST; Kollef KE; Reichley RM; Roubinian N; Kollef MH
Antimicrob Agents Chemother; 2007 Oct; 51(10):3568-73. PubMed ID: 17682100
[TBL] [Abstract][Full Text] [Related]
13. [Stepdown ofloxacin therapy in bronchopulmonary diseases].
Nonikov VE; Lenkova NI; Makarova OV; Ritchik LA
Antibiot Khimioter; 1996; 41(9):50-2. PubMed ID: 9005787
[TBL] [Abstract][Full Text] [Related]
14. Salvage treatment of pneumonia and initial treatment of tracheobronchitis caused by multidrug-resistant Gram-negative bacilli with inhaled polymyxin B.
Pereira GH; Muller PR; Levin AS
Diagn Microbiol Infect Dis; 2007 Jun; 58(2):235-40. PubMed ID: 17350201
[TBL] [Abstract][Full Text] [Related]
15. Clinical experience with parenteral and oral ofloxacin in severe infections.
Kanellakopoulou K; Giamarellou H
Scand J Infect Dis Suppl; 1990; 68():64-9. PubMed ID: 2218425
[TBL] [Abstract][Full Text] [Related]
16. Ofloxacin versus standard therapy in treatment of community-acquired pneumonia requiring hospitalization. Pneumonia Study Group.
Plouffe JF; Herbert MT; File TM; Baird I; Parsons JN; Kahn JB; Rielly-Gauvin KT
Antimicrob Agents Chemother; 1996 May; 40(5):1175-9. PubMed ID: 8723461
[TBL] [Abstract][Full Text] [Related]
17. Characteristics of Klebsiella pneumoniae bacteremia in community-acquired and nosocomial infections in diabetic patients.
Tsai SS; Huang JC; Chen ST; Sun JH; Wang CC; Lin SF; Hsu BR; Lin JD; Huang SY; Huang YY
Chang Gung Med J; 2010; 33(5):532-9. PubMed ID: 20979704
[TBL] [Abstract][Full Text] [Related]
18. Ofloxacin in the treatment of lower respiratory tract infections: report of a prospective, comparative trial.
Khajotia RR; Vetter N; Harazin H
Clin Ther; 1991; 13(4):460-6. PubMed ID: 1933997
[TBL] [Abstract][Full Text] [Related]
19. Diagnosis and treatment of community-acquired and hospital-acquired pneumonia.
Foster MT
Pharmacotherapy; 1993; 13(2 Pt 2):45S-50S. PubMed ID: 8474938
[TBL] [Abstract][Full Text] [Related]
20. Follow-up protected specimen brushes to assess treatment in nosocomial pneumonia.
Montravers P; Fagon JY; Chastre J; Lecso M; Dombret MC; Trouillet JL; Gibert C
Am Rev Respir Dis; 1993 Jan; 147(1):38-44. PubMed ID: 8420428
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
